Michel Dubois
Director/Board Member chez GENEURO SA
Profil
Michel Dubois is currently a Director at GeNeuro SA, a Director at Centre Hospitalier Saint Joseph - Saint Luc, and an Independent Director at GeNeuro SA (Switzerland).
He previously served as Chairman at Transgene SA, Biotek Partenaires SAS, TSGH SAS, and GeNeuro Innovation SAS.
He was also an Independent Director at Stallergenes SA and General Director at Institut Mérieux SA. Additionally, he worked as a Manager at ANO Consultants & Participations SARL.
Mr. Dubois holds a graduate degree from Université Paris 1 Panthéon-Sorbonne and an undergraduate degree from Sciences Po.
Postes actifs de Michel Dubois
| Sociétés | Poste | Début |
|---|---|---|
| GENEURO SA | Director/Board Member | 16/07/2008 |
GeNeuro SA
 GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The private company is based in Lyon, France. | Director/Board Member | 26/07/2010 |
| Centre Hospitalier Saint Joseph - Saint Luc | Director/Board Member | - |
Anciens postes connus de Michel Dubois
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSGENE | Chairman | 17/06/2010 |
| ANO Consultants & Participations SARL | Corporate Officer/Principal | 01/01/2010 |
Biotek Partenaires SAS
 Biotek Partenaires SAS Investment ManagersFinance Biotek Partenaires SAS (Biotek Partenaires) is a venture capital firm, a subsidiary of Banque Saint Olive. The firm is founded in 1998 by Saint-Olive. The firm headquartered in Lyon, France. | Chairman | 27/04/2009 |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Chief Executive Officer | - |
GeNeuro Innovation SAS
 GeNeuro Innovation SAS Miscellaneous Commercial ServicesCommercial Services Part of GeNeuro SA (Switzerland), GeNeuro Innovation SAS is a French company that specializes in developing therapeutic products for the treatment of neurological disorders such as multiple sclerosis, schizophrenia, and autoimmune disorders like diabetes. The private company focuses on developing new therapeutics that address nervous system pathologies involving human endogenous retroviruses (HERVs). | Chairman | - |
Formation de Michel Dubois
| Université Paris 1 Panthéon-Sorbonne | Graduate Degree |
| Sciences Po | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TRANSGENE | Health Technology |
| GENEURO SA | Health Technology |
| Entreprise privées | 8 |
|---|---|
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Biotek Partenaires SAS
Biotek Partenaires SAS Investment ManagersFinance Biotek Partenaires SAS (Biotek Partenaires) is a venture capital firm, a subsidiary of Banque Saint Olive. The firm is founded in 1998 by Saint-Olive. The firm headquartered in Lyon, France. | Finance |
TSGH SAS
 TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Finance |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Health Technology |
GeNeuro SA
GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The private company is based in Lyon, France. | Health Technology |
| ANO Consultants & Participations SARL | |
| Centre Hospitalier Saint Joseph - Saint Luc | |
GeNeuro Innovation SAS
GeNeuro Innovation SAS Miscellaneous Commercial ServicesCommercial Services Part of GeNeuro SA (Switzerland), GeNeuro Innovation SAS is a French company that specializes in developing therapeutic products for the treatment of neurological disorders such as multiple sclerosis, schizophrenia, and autoimmune disorders like diabetes. The private company focuses on developing new therapeutics that address nervous system pathologies involving human endogenous retroviruses (HERVs). | Commercial Services |
